CLNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
COLGATE PALMOLIVE CO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$93.39−0.72 (-0.77%)
Close on Oct 19, 2026
- Market cap
- $74.88B
- P/E (TTM)
- 37.1
- Dividend yield
- 2.23%
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
60.1%−0.7 pts over 5 years
Operating margin
16.2%−7.4 pts over 5 years
Net margin
10.5%−5.9 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +1.4% | +4.3% | +4.4% | +2.4% | |
| Gross profit | +0.7% | +6.1% | +4.1% | +2.7% | |
| Operating income | -22.5% | +4.5% | -3.2% | +1.7% | |
| Net income | -26.2% | +6.1% | -4.6% | +4.4% | |
| EPS, diluted | -25.1% | +7.3% | -3.5% | +5.6% | |
| Free cash flow | +2.5% | +25.0% | +1.9% | +4.9% | |
| Dividend per share | -16.1% | +3.8% | +3.5% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | -900.7% | 626.7% | 1603.0% | |
| Return on assets | 20.3% | 17.4% | 13.2% | |
| Current ratio | 1.31 | 0.99 | 0.83 | |
| Debt to equity | -26.83 | 9.88 | 147.89 | |
| Net debt to EBITDA | 1.18× | 1.46× | 1.70× | |
| Interest coverage | 25.5× | 21.1× | 12.4× | |
| Inventory turnover | 5.2× | 4.2× | 4.0× | |
| Capex to revenue | 3.9% | 2.5% | 2.8% | |
| Diluted shares | 898M | 859M | 811M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Colgate Palmolive generated $17.93B from operations and spent $9.80B on capital expenditure, dividends and share buybacks. 32% of that went back into the business.
Generated
$17.93B
Used
$9.80B
Capital expenditure$3.09B32%Dividends$00%Share buybacks$6.71B68%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin10.5%
×Asset turnover1.26×
×Equity multiplier121.71×
=Return on equity, FY20251603.0%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 10.5% | 1.26× | 121.71× | 1603.0% |
| FY2024 | 14.4% | 1.24× | 39.51× | 703.8% |
| FY2023 | 11.8% | 1.21× | 31.81× | 455.4% |
| FY2022 | 9.9% | 1.17× | 30.47× | 353.5% |
| FY2021 | 12.4% | 1.13× | 22.90× | 320.4% |
| FY2020 | 16.4% | 1.06× | 35.99× | 626.7% |
| FY2019 | 15.1% | 1.15× | 1813.00× | 31560.0% |
| FY2018 | 15.4% | 1.25× | -153.31× | -2963.0% |
| FY2017 | 13.1% | 1.25× | -81.84× | -1336.0% |
| FY2016 | 16.1% | 1.26× | -44.39× | -900.7% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
6of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero$2.13B
- Cash generatingOperating cash flow above zero$4.20B
- Return on assets improvedROA up on the prior year17.6% → 13.3%
- Earnings backed by cashOperating cash flow above net income$4.20B vs $2.13B
- Less leverageLong-term debt to assets fell45.4% → 42.1%
- Better liquidityCurrent ratio rose0.92 → 0.83
- No dilutionShare count did not rise823M → 811M
- Gross margin improvedGross margin up on the prior year60.50% → 60.11%
- More efficientAsset turnover rose1.23 → 1.27